Definium Therapeutics Inc. Common Shares vs iShares 1 3 Year Treasury Bond ETF — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while iShares 1 3 Year Treasury Bond ETF trades at $81.21 (market cap $26.63B). The key difference: iShares 1 3 Year Treasury Bond ETF is far larger — about 5.7× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and iShares 1 3 Year Treasury Bond ETF for 63 Days on average.
| DFTX | SHY | |
|---|---|---|
Market Cap | $4.71B | $26.63B |
Volume | 1,966,636 | 4,081,431 |
Sector | Health | Fixed Income |
52-Week High | $48.45 | $83.18 |
52-Week Low | $10.68 | $81.05 |
Typical Hold Time | 0 Days | 63 Days |
Enterprise Value | $3.67B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SHY is trading at $81.16 with minimal daily movement (+0.04%), showing stability amid broader bond market volatility. The technical picture remains bearish with moving averages signaling downward pressure, while oscillators suggest neutral momentum. Recent corporate actions include consistent dividend payments, with the latest being $0.24 per share. The fund operates in a challenging interest rate environment where short-term bond ETFs face both opportunities and headwinds from Federal Reserve policy shifts.
The outlook for SHY is mixed, with potential benefits from rising short-term yields but significant pressure from the ongoing bond market selloff. Investment opportunities include exposure to increasing interest rates with limited duration risk, while risks encompass continued bond market volatility and macroeconomic uncertainty driving yields higher. The fund's stability and dividend consistency provide some defensive characteristics in turbulent markets.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →